| (Values in U.S. Thousands) | Dec, 2017 | Dec, 2016 | Dec, 2015 | Dec, 2014 | Dec, 2013 |
| Sales | 49,980 | 54,570 | 37,560 | 32,460 | 29,230 |
| Sales Growth | -8.41% | +45.29% | +15.71% | +11.05% | +13.16% |
| Net Income | -2,060 | 5,950 | -2,130 | 3,390 | 6,700 |
| Net Income Growth | -134.62% | +379.34% | -162.83% | -49.40% | -32.46% |
Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Juniper Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is focused on developing therapeutics for women's health. Juniper Pharmaceuticals, Inc., formerly known as COLUMBIA LABS, is based in Boston, United States.
Fiscal Year End Date: 12/31